Published in Biochem Pharmacol on April 15, 1984
Exploring the Role of Residue 228 in Substrate and Inhibitor Recognition by VIM Metallo-β-lactamases. Biochemistry (2015) 0.93
BW A575C, a chemically novel agent with angiotensin converting enzyme inhibitor and beta-adrenoceptor-blocking properties. Br J Pharmacol (1987) 0.77
A detailed physiologically based model to simulate the pharmacokinetics and hormonal pharmacodynamics of enalapril on the circulating endocrine Renin-Angiotensin-aldosterone system. Front Physiol (2013) 0.75
Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo. Br J Pharmacol (1988) 2.02
Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr Biol (1994) 1.80
Citrate utilization by Escherichia coli: plasmid- and chromosome-encoded systems. J Bacteriol (1983) 1.28
The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience (1997) 1.21
Anion-binding to liver alcohol dehydrogenase, studied by rate of alkylation. Eur J Biochem (1969) 1.19
Activation of casein kinase II by sphingosine. J Biol Chem (1991) 1.09
Equilibrium binding of coenzymes and substrates to nicotinamide-adenine dinucleotide phosphate-linked isocitrate dehydrogenase from bovine heart mitochondria. Biochem J (1978) 1.08
Transient kinetics of nicotinamide-adenine dinucleotide phosphate-linked isocitrate dehydrogenase from bovine heart mitochondria. Biochem J (1978) 1.07
Complexes of liver alcohol dehydrogenase. Further studies on the rate of inactivation. Eur J Biochem (1970) 1.07
Sites of phosphorylation in tau and factors affecting their regulation. Biochem Soc Symp (2001) 1.06
Conformational analysis of the eight-membered ring of the oxidized cysteinyl-cysteine unit implicated in nicotinic acetylcholine receptor ligand recognition. J Am Chem Soc (2001) 1.00
Residual activity in carboxymethylated liver alcohol dehydrogenase. Biochem J (1970) 0.96
Inhibition of calmodulin-activated cyclic nucleotide phosphodiesterase: multiple binding-sites for tricyclic drugs on calmodulin. Biochem Pharmacol (1982) 0.94
Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly. Biochem J (1997) 0.92
GB/SA water model for the Merck molecular force field (MMFF). J Mol Graph Model (2000) 0.88
Transient kinetic studies of malic enzyme. A conformational change associated with substrate inhibition by malate. Arch Biochem Biophys (1978) 0.83
Stimulation of MAP kinase by v-raf transformation of fibroblasts fails to induce hyperphosphorylation of transfected tau. FEBS Lett (1995) 0.83
The role of phosphoenolpyruvate in insulin secretion: the effect of L-phenylalanine. Experientia (1984) 0.83
Heparin cofactor II: cDNA sequence, chromosome localization, restriction fragment length polymorphism, and expression in Escherichia coli. Biochemistry (1988) 0.82
Simulations of the roles of multiple cyclic nucleotide phosphodiesterases. Biochem J (1982) 0.81
Purification and molecular properties of NADP-linked isocitrate dehydrogenase from ox heart mitochondria [proceedings]. Biochem Soc Trans (1977) 0.79
Carboxymethyl horse-liver alcohol dehydrogenase. Ligand-binding and kinetic properties of the cysteine-46-modified enzyme. Arch Biochem Biophys (1975) 0.78
Determination of the stability constants of Mn2+ and Mg2+ complexes of the components of the NADP-linked isocitrate dehydrogenase reaction by electron spin resonance. Eur J Biochem (1980) 0.78
Oxidative stress induces dephosphorylation of tau in rat brain primary neuronal cultures. J Neurochem (1997) 0.78
Immunological and kinetic properties of pyruvate kinase in rat pancreatic islets. Biochem J (1982) 0.78
Activation and inactivation of phosphoenolpyruvate carboxykinase by ferrous ions. Biochem J (1980) 0.78
Activation of human erythrocyte 2,3-bisphosphoglycerate phosphatase at physiological concentrations of substrate. Arch Biochem Biophys (1986) 0.77
Mormonism and birth planning: the discrepancy between church authorities' teachings and lay attitudes. Popul Stud (Camb) (1972) 0.77
Specific glycosaminoglycans support the inhibition of thrombin by plasminogen activator inhibitor 1. Biochemistry (1993) 0.77
Phosphoenolpyruvate carboxykinase: effects of the hyperglycaemic agent 3-aminopicolinic acid. Biochem Pharmacol (1980) 0.76
Improved AMBER torsional parameters for the N-N rotational barrier in diacylhydrazines. J Mol Graph Model (2000) 0.76
Modeling the reactivity of acrylic acid and acrylate anion with biological nucleophiles. Toxicol Lett (1989) 0.75
Conformation changes in chemically modified alcohol dehydrogenase. Biochem J (1971) 0.75
Letter: Assay of serum enzymes in trypanosomal infection: interference by pyruvate. Trans R Soc Trop Med Hyg (1973) 0.75
The NAD-linked alpha-glycerophosphate dehydrogenase of trypanosomes. Biochem Biophys Res Commun (1975) 0.75
Expression of the mouse c-abl type IV proto-oncogene product in the insect cell baculovirus system. Biochim Biophys Acta (1992) 0.75
Equilibria for the adsorption of antibiotics onto neutral polymeric sorbents: Experimental and modeling studies. Biotechnol Bioeng (1995) 0.75
Factors affecting coenzyme binding and subunit interactions in glyceraldehyde-3-phosphate dehydrogenase. Biochim Biophys Acta (1979) 0.75
Thiol groups of liver alcohol dehydrogenase. Accessibility to general thiol reagents and to potential affinity-labels. FEBS Lett (1974) 0.75